Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Enterprise Value (2016 - 2025)

Mimedx (MDXG) has disclosed Enterprise Value for 15 consecutive years, with -$166.1 million as the latest value for Q4 2025.

  • Quarterly Enterprise Value fell 59.1% to -$166.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$166.1 million through Dec 2025, down 59.1% year-over-year, with the annual reading at -$166.1 million for FY2025, 59.1% down from the prior year.
  • Enterprise Value hit -$166.1 million in Q4 2025 for Mimedx, down from -$142.1 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$48.5 million in Q1 2024 to a low of -$166.1 million in Q4 2025.
  • Historically, Enterprise Value has averaged -$89.0 million across 5 years, with a median of -$84.7 million in 2021.
  • Biggest five-year swings in Enterprise Value: increased 24.27% in 2022 and later tumbled 119.5% in 2025.
  • Year by year, Enterprise Value stood at -$87.1 million in 2021, then increased by 24.27% to -$66.0 million in 2022, then fell by 24.34% to -$82.0 million in 2023, then dropped by 27.34% to -$104.4 million in 2024, then plummeted by 59.1% to -$166.1 million in 2025.
  • Business Quant data shows Enterprise Value for MDXG at -$166.1 million in Q4 2025, -$142.1 million in Q3 2025, and -$118.9 million in Q2 2025.